318 related articles for article (PubMed ID: 32270928)
1. Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity.
Blair CA; Pruitt BL
Adv Healthc Mater; 2020 Apr; 9(8):e1901656. PubMed ID: 32270928
[TBL] [Abstract][Full Text] [Related]
2. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
3. Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
Narkar A; Willard JM; Blinova K
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328619
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced Cardiotoxicity.
Lyra-Leite DM; Burridge PW
Curr Cardiol Rep; 2020 Jun; 22(8):56. PubMed ID: 32562096
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.
Cui N; Wu F; Lu WJ; Bai R; Ke B; Liu T; Li L; Lan F; Cui M
J Cell Mol Med; 2019 Jul; 23(7):4627-4639. PubMed ID: 31106979
[TBL] [Abstract][Full Text] [Related]
6. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Sureshkumar P; Vinken M; Ates G; Rogiers V; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2018 Jan; 92(1):371-381. PubMed ID: 28940058
[TBL] [Abstract][Full Text] [Related]
7. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
8. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.
Kopljar I; De Bondt A; Vinken P; Teisman A; Damiano B; Goeminne N; Van den Wyngaert I; Gallacher DJ; Lu HR
Br J Pharmacol; 2017 Nov; 174(21):3766-3779. PubMed ID: 28094846
[TBL] [Abstract][Full Text] [Related]
9. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W
Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810
[TBL] [Abstract][Full Text] [Related]
10. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity.
Sharma A; McKeithan WL; Serrano R; Kitani T; Burridge PW; Del Álamo JC; Mercola M; Wu JC
Nat Protoc; 2018 Dec; 13(12):3018-3041. PubMed ID: 30413796
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers.
Monteiro da Rocha A; Allan A; Block T; Creech J; Herron TJ
J Vis Exp; 2023 Mar; (193):. PubMed ID: 37036202
[TBL] [Abstract][Full Text] [Related]
12. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
13. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
Andrysiak K; Stępniewski J; Dulak J
Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
[TBL] [Abstract][Full Text] [Related]
14. An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes.
Wang R; Wang M; Wang S; Yang K; Zhou P; Xie X; Cheng Q; Ye J; Sun G; Sun X
Stem Cell Res Ther; 2019 Jan; 10(1):20. PubMed ID: 30635051
[TBL] [Abstract][Full Text] [Related]
15. Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association.
Gintant G; Burridge P; Gepstein L; Harding S; Herron T; Hong C; Jalife J; Wu JC
Circ Res; 2019 Oct; 125(10):e75-e92. PubMed ID: 31533542
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.
Sachinidis A
Cells; 2020 Apr; 9(4):. PubMed ID: 32316481
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.
Zwartsen A; de Korte T; Nacken P; de Lange DW; Westerink RHS; Hondebrink L
J Mol Cell Cardiol; 2019 Nov; 136():102-112. PubMed ID: 31526813
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
20. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
